Ad Alert

Discover CBD

Unapproved drug treatment claims remain in wake of FDA warning letter.

A seller of purported CBD and THC products recently discovered how the FDA feels about drug treatment claims being made without the agency’s required approval.

Last month, the FDA sent a warning letter to Discover Health LLC (doing business as Discover CBD and Strain Snobs) regarding unapproved claims appearing on the company’s websites that its oils, gummies and lotions treat a variety of serious diseases including breast cancer, epilepsy and PTSD.

To date, the FDA has only approved one CBD product, a prescription drug to treat seizures associated with certain diseases, and two products containing synthetic THC for cancer and AIDS patients that are also only available with a prescription from a licensed healthcare provider. Another FDA-approved prescription drug for cancer patients has a chemical structure similar to THC and is synthetically derived.

While Discover CBD has addressed many of the unapproved drug treatment claims by simply removing the posts in which they appeared, problematic claims remain. For example, as of this writing, the company has yet to take down a post titled, CBD & Opioid Addiction. Among the claims cited by the FDA that remain on the page is one that states that:

Although there hasn’t been a lot of research with CBD in the field of addiction, all signs point toward more studies being done to try to find the answers and help bring an end to the opioid epidemic. With over 60,000 deaths in 2016 we desperately need something to help, and CBD may just be the answer. reached out to Discover CBD for comment. Check back for updates.

Find more of our coverage on CBD products here.

Our Ad Alerts are not just about false and deceptive marketing issues, but may also be about ads that, although not necessarily deceptive, should be viewed with caution. Ad Alerts can also be about single issues and may not include a comprehensive list of all marketing issues relating to the brand discussed.

You Might Be Interested In